Gryphon Financial Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Buy |
5,203
+772
| +17% | +$53.3K | 0.05% | 226 |
|
|
2025
Q1 | $308K | Buy |
4,431
+1,045
| +31% | +$72.6K | 0.04% | 212 |
|
|
2024
Q4 | $291K | Buy |
3,386
+61
| +2% | +$5.25K | 0.04% | 211 |
|
|
2024
Q3 | $396K | Buy |
3,325
+239
| +8% | +$28.5K | 0.05% | 193 |
|
|
2024
Q2 | $440K | Buy |
3,086
+1,116
| +57% | +$159K | 0.07% | 178 |
|
|
2024
Q1 | $253K | Sell |
1,970
-324
| -14% | -$41.6K | 0.04% | 226 |
|
|
2023
Q4 | $237K | Buy |
+2,294
| New | +$237K | 0.04% | 208 |
|
|
2018
Q3 | – | Sell |
-426
| Closed | -$9K | – | 629 |
|
|
2018
Q2 | $9K | Hold |
426
| – | – | ﹤0.01% | 538 |
|
|
2018
Q1 | $11K | Sell |
426
-222
| -34% | -$5.73K | 0.01% | 505 |
|
|
2017
Q4 | $18K | Buy |
+648
| New | +$18K | 0.01% | 421 |
|